Market Overview:
The global B4GN4 antibody market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies (mAbs) and polyclonal antibodies (pAbs) for research and therapeutic applications. Additionally, the increasing prevalence of chronic diseases is also contributing to the growth of this market. The global B4GN4 antibody market by type is segmented into mAbs and pAbs. The mAb segment is expected to grow at a higher CAGR than the pAb segment during the forecast period from 2018 to 2030. This can be attributed to the growing demand for mAbs in research and therapeutic applications owing to their high specificity and affinity towards their target molecules. On basis of application,the global B4GN4 antibody market is divided into bioScience companies, hospitals & clinics, universities & institutions,and others segments .
Product Definition:
B4GN4 Antibody is used for the detection of B4GN4 antigen. It is important for the diagnosis of diseases associated with B4GN4 antigen.
pAbs:
pAbs is short for plasma-derived Abs. It's an immune response to an antigen challenge and it helps in protection against various pathogens. pAbs can be manufactured by the body itself or purchased from commercial sources like immunoprecipitation companies or antibody-generating units (AGUs).
mAb:
mAb is short for monoclonal antibody. It is a protein, which is produced by B cells and T cells in the body. The antibodies are made to fight against specific harmful substances that our body detects as foreign objects. There are various types of mAbs such as humanized, fully human, chimeric etc.
Application Insights:
The bio science companies segment dominated the global B4GN4 antibody market in terms of revenue share in 2017. This is owing to factors such as an increase in R&D activities pertaining to biologics production and growing emphasis on product development. For instance, FBS International LLC has a collaboration with Uppsala University for developing therapeutic antibodies for cancer treatment using its proprietary cell-based immunotherapy platform.
The hospitals and clinics segment is expected to witness lucrative growth over the forecast period due to increasing prevalence of chronic diseases, especially diabetes, which requires regular blood tests and monitoring throughout the course of treatment. Moreover, rising healthcare costs coupled with a focus on improving patient outcomes through innovative treatments are driving this sector towards greater heights across the globe.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of biotechnology and biopharmaceutical companies, which are engaged in drug discovery and development activities, is one of the major factors contributing to this dominance. Moreover, increasing R&D investments by these companies coupled with growing adoption of b4golntx as a research tool for drug discovery is expected to drive the North American regional market over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by various governments along with an increase in investment by pharmaceutical and biotech firms for drug discovery activities.
Growth Factors:
- Increasing prevalence of autoimmune diseases: The global prevalence of autoimmune diseases is increasing every year. This is expected to drive the demand for B4GN4 antibody in the coming years.
- Growing awareness about B4GN4 antibody: There is a growing awareness among people about the benefits of using B4GN4 antibody for treating various medical conditions. This is likely to boost the demand for this product in the near future.
- Rising R&D expenditure by pharmaceutical companies: Pharmaceutical companies are investing heavily in R&D activities to develop new and innovative therapies using B4GN4 antibody. This is likely to create new growth opportunities for this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
B4GN4 Antibody Market Research Report
By Type
pAbs, mAb
By Application
BioScience Companies, Hospitals and Clinics, University and Institutions, Others
By Companies
Atlas Antibodies, Sigmaaldrich, Abcam, Biocompare, RandD Systems, Thermo Fisher Scientific, Cosmic(UK), Atlas Antibodies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global B4GN4 Antibody Market Report Segments:
The global B4GN4 Antibody market is segmented on the basis of:
Types
pAbs, mAb
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
BioScience Companies, Hospitals and Clinics, University and Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atlas Antibodies
- Sigmaaldrich
- Abcam
- Biocompare
- RandD Systems
- Thermo Fisher Scientific
- Cosmic(UK)
- Atlas Antibodies
Highlights of The B4GN4 Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- pAbs
- mAb
- By Application:
- BioScience Companies
- Hospitals and Clinics
- University and Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the B4GN4 Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
B4GN4 is an antibody that specifically recognizes the B4Gn protein.
Some of the key players operating in the b4gn4 antibody market are Atlas Antibodies, Sigmaaldrich, Abcam, Biocompare, RandD Systems, Thermo Fisher Scientific, Cosmic(UK), Atlas Antibodies.
The b4gn4 antibody market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 B4GN4 Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 B4GN4 Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 B4GN4 Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the B4GN4 Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global B4GN4 Antibody Market Size & Forecast, 2018-2028
4.5.1 B4GN4 Antibody Market Size and Y-o-Y Growth
4.5.2 B4GN4 Antibody Market Absolute $ Opportunity
Chapter 5 Global B4GN4 Antibody Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 B4GN4 Antibody Market Size Forecast by Type
5.2.1 pAbs
5.2.2 mAb
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global B4GN4 Antibody Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 B4GN4 Antibody Market Size Forecast by Applications
6.2.1 BioScience Companies
6.2.2 Hospitals and Clinics
6.2.3 University and Institutions
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global B4GN4 Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 B4GN4 Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America B4GN4 Antibody Analysis and Forecast
9.1 Introduction
9.2 North America B4GN4 Antibody Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America B4GN4 Antibody Market Size Forecast by Type
9.6.1 pAbs
9.6.2 mAb
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America B4GN4 Antibody Market Size Forecast by Applications
9.10.1 BioScience Companies
9.10.2 Hospitals and Clinics
9.10.3 University and Institutions
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe B4GN4 Antibody Analysis and Forecast
10.1 Introduction
10.2 Europe B4GN4 Antibody Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe B4GN4 Antibody Market Size Forecast by Type
10.6.1 pAbs
10.6.2 mAb
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe B4GN4 Antibody Market Size Forecast by Applications
10.10.1 BioScience Companies
10.10.2 Hospitals and Clinics
10.10.3 University and Institutions
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific B4GN4 Antibody Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific B4GN4 Antibody Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific B4GN4 Antibody Market Size Forecast by Type
11.6.1 pAbs
11.6.2 mAb
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific B4GN4 Antibody Market Size Forecast by Applications
11.10.1 BioScience Companies
11.10.2 Hospitals and Clinics
11.10.3 University and Institutions
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America B4GN4 Antibody Analysis and Forecast
12.1 Introduction
12.2 Latin America B4GN4 Antibody Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America B4GN4 Antibody Market Size Forecast by Type
12.6.1 pAbs
12.6.2 mAb
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America B4GN4 Antibody Market Size Forecast by Applications
12.10.1 BioScience Companies
12.10.2 Hospitals and Clinics
12.10.3 University and Institutions
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) B4GN4 Antibody Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) B4GN4 Antibody Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) B4GN4 Antibody Market Size Forecast by Type
13.6.1 pAbs
13.6.2 mAb
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) B4GN4 Antibody Market Size Forecast by Applications
13.10.1 BioScience Companies
13.10.2 Hospitals and Clinics
13.10.3 University and Institutions
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 B4GN4 Antibody Market: Competitive Dashboard
14.2 Global B4GN4 Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Atlas Antibodies
14.3.2 Sigmaaldrich
14.3.3 Abcam
14.3.4 Biocompare
14.3.5 RandD Systems
14.3.6 Thermo Fisher Scientific
14.3.7 Cosmic(UK)
14.3.8 Atlas Antibodies
